Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

The Gilead Effect
The Morning Consult
Tue, 10/14/14 - 08:38 am
Tags:
Gilead Sciences, drug pricing, Sovaldi
Companies That Could Develop An Enterovirus Treatment
Yahoo/Benzinga
Mon, 10/13/14 - 09:16 am
Tags:
enterovirus, AbbVie, Alnylam, Gilead Sciences, Bristol-Myers Squibb, Merck, Biocryst, Chimerix, Tekmira, Sarepta Therapeutics
Gilead Wins U.S. Approval for Hepatitis C Combo Pill
Bloomberg
Fri, 10/10/14 - 05:51 pm
Tags:
Gilead Sciences, FDA, Harvoni, hepatitis C
As Hepatitis Pill Harvoni Joins Sovaldi, States Erect Medicaid Hurdles
Forbes
Fri, 10/10/14 - 09:10 am
Tags:
Harvoni, Sovaldi, Medicaid, hepatitis C, Gilead Sciences
Does Gilead Sciences Have a European Problem?
Barron's
Wed, 10/8/14 - 01:07 pm
Tags:
Gilead Sciences, Europe, Sovaldi
Gilead Sciences: Here Comes the Competition
Barron's
Tue, 10/7/14 - 01:21 pm
Tags:
Gilead Sciences, hepatitis C, Sovaldi, Merck, AbbVie, Idenix, Bristol-Myers Squibb, Achillion
Sovaldi may be cost-effective, but the U.K. can't afford it, documents say
Fierce Pharma
Tue, 10/7/14 - 08:09 am
Tags:
Sovaldi, UK, drug pricing, Gilead Sciences, hepatitis C
Will Biotech Beat This Earnings Season?
Barron's
Mon, 10/6/14 - 06:05 pm
Tags:
earnings, Gilead Sciences, Celgene, Biogen Idec
Gilead Outperforms Biotech Sector Over Success Of Sovaldi, Harvoni, And Zydelig
Bidness Etc.
Mon, 10/6/14 - 07:42 am
Tags:
Gilead Sciences, Sovaldi, Harvoni, Zydelig
Biopharmaceutical companies are now increasingly relocating patent rights to overseas markets to lower their tax burden
Bidness Etc.
Wed, 10/1/14 - 08:09 am
Tags:
tax inversions, intellectual property, Gilead Sciences, Alexion
Pharma Events To Watch Out For This Week
Bidness Etc.
Mon, 09/29/14 - 01:15 pm
Tags:
Salix, Progenics, Relistor, AASLD, Merck, Gilead Sciences, AbbVie, Intercept Pharma
Gilead's HIV Drugs Tybost and Vitekta Get FDA Clearance
Yahoo/Zacks
Sat, 09/27/14 - 09:31 am
Tags:
Gilead Sciences, Tybost, Vitekta, HIV
Can Gilead Sciences Be A Do-Gooder And Still Do Well?
Investor's.com
Sat, 09/27/14 - 09:23 am
Tags:
Gilead Sciences, Sovaldi
Gilead’s Hepatitis C Combination Wins EU Agency Backing
Bloomberg
Fri, 09/26/14 - 09:02 am
Tags:
Gilead Sciences, hepatitis C, Europe, Sovaldi, ledipasvir
Gilead, Celgene Key Holdings Of Top Health Care Fund
Investors.com
Fri, 09/26/14 - 09:01 am
Tags:
Gilead Sciences, Celgene
Generic Sovaldi makers could pocket upwards of $600m says analyst
In-Pharma Technologist
Thu, 09/25/14 - 09:25 am
Tags:
generics, Sovaldi, Gilead Sciences, hepatitis C, Mylan, Strides Arcolab, Cadila, Cipla, Hetero Labs, Ranbaxy, Sequent Scientific
Gilead's New HIV Drug Key To Long-Term Strategy
Investors.com
Wed, 09/24/14 - 06:43 pm
Tags:
Gilead Sciences, HIV, tenofovir
Key Pharma Events For the Week Ahead
Bidness Etc.
Mon, 09/22/14 - 03:47 pm
Tags:
Celgene, Otezla, CHMP, Gilead Sciences, Roche, Novartis, Merck, Eli Lilly, JNJ, GSK, Sanofi, Teva
Gilead Sciences: A Preview of Important HIV Drug Study Results
TheStreet.com
Mon, 09/22/14 - 02:48 pm
Tags:
Gilead Sciences, HIV, tenofovir
3 Stocks Pulling The Drugs Industry Downward
TheStreet.com
Mon, 09/22/14 - 02:42 pm
Tags:
AbbVie, Pfizer, Gilead Sciences

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.